scholarly journals Prospects of using biological products in vitiligo

2020 ◽  
Vol 23 (1) ◽  
pp. 39-41
Author(s):  
A. R. Tavitova ◽  
A. A. Krinitsyna ◽  
K. M. Lomonosov

A literature review is presented regarding the vitiligo reaction to biological agents for treating this dermatosis itself and as a side effect of the treatment of other diseases. Notably, the results of therapy with biological products and the researchers opinions on this subject are ambiguous because of the positive evidence of repigmentation of vitiligo foci, as well as cases of vitiligo in patients who received biological products for the treatment of another pathology.

Author(s):  
Enrique Iglesias Julián ◽  
Ester Badía Aranda ◽  
Belén Bernad Cabredo ◽  
Daniel Corrales Cruz ◽  
María José Romero Arauzo

2014 ◽  
Vol 18 ◽  
pp. 120-131
Author(s):  
L.М. Tokmakova ◽  
Yu.О. Tararyko ◽  
А.O. Trepach ◽  
О.P. Lepekhа ◽  
І.V. Larchenko

The influence of seed protectants crop viability and functional activity of bacterial cells - biological agents microbial preparations. The possibility of the use of protectants compatible with biological products, bio-agents which exhibit resistance to the pesticide active ingredient.


2011 ◽  
Vol 2011 ◽  
pp. 1-9 ◽  
Author(s):  
Nikhil Nihalani ◽  
Thomas L. Schwartz ◽  
Umar A. Siddiqui ◽  
James L. Megna

A majority of psychiatric medications are known to generate weight gain and ultimately obesity in some patients. There is much speculation about the prevalence of weight gain and the degree of weight gain during acute and longitudinal treatment with these agents. There is newer literature looking at the etiology of this weight gain and the potential treatments being used to alleviate this side effect. The authors undertook a comprehensive literature review in order to present epidemiology, etiology, and treatment options of weight gain associated with antipsychotics, mood stabilizers, and antidepressants.


Vaccines ◽  
2021 ◽  
Vol 9 (11) ◽  
pp. 1251
Author(s):  
Hui Min Tan ◽  
Susan Swee-Shan Hue ◽  
Aileen Wee ◽  
Kay Choong See

With the rapid development of various coronavirus disease 2019 (COVID-19) vaccines in a bid to counter and contain the COVID-19 pandemic, unusual and uncommon side effects of COVID-19 vaccination have been increasingly reported in the literature. Ipsilateral lymphadenopathy is a fairly common side effect of vaccination of any kind, with its etiology most commonly related to reactive lymphadenopathy. However, Kikuchi–Fujimoto Disease (KFD) or necrotizing histiocytic lymphadenitis is rarely observed post-vaccination, with only one other case of KFD post COVID-19 vaccination reported to date. We report two more cases of KFD post COVID-19 vaccination in the Asian population, highlighting the clinical course and salient clinical, radiological and histologic findings. In addition, we provide a literature review of the existing cases of lymphadenopathy post COVID-19 vaccination with cytologic and/or histologic correlation.


2001 ◽  
Vol 25 (6) ◽  
pp. 232-233 ◽  
Author(s):  
King Han Kho ◽  
Olaf Nielsen

Aims and MethodTo report the management of three cases of clozapine-induced enuresis, by description of these cases and literature review.ResultsHeavy sedation, generalised epilepsy and diabetes mellitus induced by clozapine are some of the mechanisms that underlie the emergence of this side-effect.Clinical ImplicationsThese cases illustrate several different pathophysiological mechanisms necessitating further diagnostic investigations before adequate treatment can be started. Clozapine-induced enuresis is probably under-reported owing to the embarrassing nature of this side-effect.


Sign in / Sign up

Export Citation Format

Share Document